Modeling Methods
In the battle between Randomized Clinical Trialists and Observational Studies Advocates, don’t forget the Modelers
This week, I’m attending the annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in Baltimore. Yesterday evening, I attended an interesting
Dr. Ward
May 23, 2011
No Comments